Form 8-K - Current report:
SEC Accession No. 0001628280-24-045112
Filing Date
2024-11-05
Accepted
2024-11-05 07:34:20
Documents
16
Period of Report
2024-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bvs-20241105.htm   iXBRL 8-K 33007
2 EX-99.1 bioventusex-991q32024.htm EX-99.1 461901
7 image_0a.jpg GRAPHIC 50612
  Complete submission text file 0001628280-24-045112.txt   759423

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20241105.xsd EX-101.SCH 2038
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bvs-20241105_def.xml EX-101.DEF 15409
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20241105_lab.xml EX-101.LAB 27075
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20241105_pre.xml EX-101.PRE 16123
18 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20241105_htm.xml XML 2919
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 241425633
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)